← SynDRA
CHLOROQUINE
SynDRA canonical compound SYN0000415 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | CYP2C8 | MRGPRX1 |
| Mechanism of action | antimalarial agent |
| Indication | amebiasis | malaria |
| Disease area | infectious disease |
All known targets
- MRGPRX1
- ACKR1
- DHFR
- TAS2R3
- SIGMAR1
- S
- PRNP
- NR4A2
- NQO2
- MTOR
- KCNH2
- CYP2C8
Mechanisms of action (all sources)
- MRGPRX1 AGONIST
- TAS2R3 AGONIST
- antimalarial agent
- ACKR1 MODULATOR
Drug classes
- Antimalarial
- Analgesics
- Analgesics, Non-Narcotic
- Anthelmintics
- Anti-Infective Agents
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antimalarials
- Antinematodal Agents
- Antiparasitic Agents
- Antiprotozoal Agents
- Antirheumatic Agents
ATC classes
Cross-references
Synonyms
- chloroquine sulfate
- chloroquine phosphate
- chloraquine
- chlorochin
- chloroquine hydrochloride
- chloroquine diphosphate
- chloroquine HCl
- chloroquine sulphate
- Cloroquina
- NSC-187208
- Amokin
- Aralen
- Aralen HCl
- Arechin
- Arechine
- Arequin
- Arolen
- Arthrochin
- Artrichin
- Avlochlor
- Avloclor
- Bemaco
- Bemaphate
- Bemasulph
- Benaquin
- Bipiquin
- CU-01000012392-2
- Capquin
- Chemochin
- Chingamin
- Chloraquine
- Chlorochin
- Chlorochine
- Chlorochinum
- Chloroin
- Chloroquin
- Chloroquina
- Chloroquine (USP/INN)
Reported adverse events
- Erythema multiforme
- Hepatitis
- Hypotension
- Maculopathy
- Pancytopenia
- Stevens-Johnson syndrome
- Urticaria
- Sensorimotor disorder
- Erythema
- Cardiac disorder
Look up CHLOROQUINE in the interactive SynDRA portal →